Cyclo Therapeutics, Inc.·4

Mar 2, 4:33 PM ET

Fine Joshua M 4

4 · Cyclo Therapeutics, Inc. · Filed Mar 2, 2022

Insider Transaction Report

Form 4
Period: 2022-02-28
Fine Joshua M
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2022-02-28+31,14131,141 total
    Exercise: $3.26Exp: 2032-02-28Common Stock (31,141 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period in equal monthly installments.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4